$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 11/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 11/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 7,500 | 180,000 | 14,168 | |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 3,898 | 93,552 | 4,166 | |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 472.14 | 100 | 47,214 | 22,498 | 22.6 K to 22.5 K (-0.44 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 471.24 | 100 | 47,124 | 22,598 | 22.7 K to 22.6 K (-0.44 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 470.97 | 142 | 66,878 | 22,698 | 22.8 K to 22.7 K (-0.62 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 469.68 | 100 | 46,968 | 22,840 | 22.9 K to 22.8 K (-0.44 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 468.92 | 100 | 46,892 | 22,940 | 23 K to 22.9 K (-0.43 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 465.42 | 500 | 232,710 | 23,040 | 23.5 K to 23 K (-2.12 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 464.44 | 500 | 232,220 | 23,540 | 24 K to 23.5 K (-2.08 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 463.60 | 1,500 | 695,400 | 24,040 | 25.5 K to 24 K (-5.87 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 462.84 | 400 | 185,136 | 25,540 | 25.9 K to 25.5 K (-1.54 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 457.91 | 3,665 | 1,678,240 | 25,940 | 29.6 K to 25.9 K (-12.38 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 457.91 | 393 | 179,959 | 29,605 | 30 K to 29.6 K (-1.31 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 7,500 | 180,000 | 29,998 | 22.5 K to 30 K (+33.34 %) |
| Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 3,898 | 93,552 | 22,498 | 18.6 K to 22.5 K (+20.96 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 30.63 | 24,375 | 746,606 | 29,236 | |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 454.00 | 400 | 181,600 | 20,029 | 20.4 K to 20 K (-1.96 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 453.28 | 1,700 | 770,576 | 20,429 | 22.1 K to 20.4 K (-7.68 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 452.61 | 3,200 | 1,448,352 | 22,129 | 25.3 K to 22.1 K (-12.63 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 450.95 | 700 | 315,665 | 25,329 | 26 K to 25.3 K (-2.69 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 450.18 | 2,093 | 942,227 | 26,029 | 28.1 K to 26 K (-7.44 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 448.87 | 300 | 134,661 | 28,122 | 28.4 K to 28.1 K (-1.06 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 448.01 | 2,600 | 1,164,826 | 28,422 | 31 K to 28.4 K (-8.38 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 444.46 | 11,703 | 5,201,515 | 31,022 | 42.7 K to 31 K (-27.39 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 444.46 | 1,679 | 746,248 | 42,725 | 44.4 K to 42.7 K (-3.78 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 30.63 | 24,375 | 746,606 | 44,404 | 20 K to 44.4 K (+121.70 %) |
| Mar 17 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | M | 59.20 | 18,311 | 1,084,011 | 54,933 | |
| Mar 17 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | M | 59.20 | 1,970 | 116,624 | 4,786 | |
| Mar 17 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Buy | M | 59.20 | 1,970 | 116,624 | 11,970 | 10 K to 12 K (+19.70 %) |
| Mar 17 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Sell | S | 450.00 | 18,311 | 8,239,950 | 10,000 | 28.3 K to 10 K (-64.68 %) |
| Mar 17 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Buy | M | 59.20 | 18,311 | 1,084,011 | 28,311 | 10 K to 28.3 K (+183.11 %) |